Nsaid Use is Associated With Worse Outcomes but Similar Benefits of Apixaban Over Warfarin in Patients With Atrial Fibrillation: Results From the ARISTOTLE Trial
Publication
, Conference
Al-Khatib, SM; Mulder, H; Wojdyla, DM; Lopes, RD; Held, C; Alexander, JH; De Caterina, R; Washam, JB; Hylek, EM; Garcia, DA; Wallentin, L; Granger, CB
Published in: CIRCULATION
2018
Duke Scholars
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
2018
Volume
138
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Al-Khatib, S. M., Mulder, H., Wojdyla, D. M., Lopes, R. D., Held, C., Alexander, J. H., … Granger, C. B. (2018). Nsaid Use is Associated With Worse Outcomes but Similar Benefits of Apixaban Over Warfarin in Patients With Atrial Fibrillation: Results From the ARISTOTLE Trial. In CIRCULATION (Vol. 138).
Al-Khatib, Sana M., Hillary Mulder, Daniel M. Wojdyla, Renato D. Lopes, Claes Held, John H. Alexander, Raffaele De Caterina, et al. “Nsaid Use is Associated With Worse Outcomes but Similar Benefits of Apixaban Over Warfarin in Patients With Atrial Fibrillation: Results From the ARISTOTLE Trial.” In CIRCULATION, Vol. 138, 2018.
Al-Khatib SM, Mulder H, Wojdyla DM, Lopes RD, Held C, Alexander JH, et al. Nsaid Use is Associated With Worse Outcomes but Similar Benefits of Apixaban Over Warfarin in Patients With Atrial Fibrillation: Results From the ARISTOTLE Trial. In: CIRCULATION. 2018.
Al-Khatib, Sana M., et al. “Nsaid Use is Associated With Worse Outcomes but Similar Benefits of Apixaban Over Warfarin in Patients With Atrial Fibrillation: Results From the ARISTOTLE Trial.” CIRCULATION, vol. 138, 2018.
Al-Khatib SM, Mulder H, Wojdyla DM, Lopes RD, Held C, Alexander JH, De Caterina R, Washam JB, Hylek EM, Garcia DA, Wallentin L, Granger CB. Nsaid Use is Associated With Worse Outcomes but Similar Benefits of Apixaban Over Warfarin in Patients With Atrial Fibrillation: Results From the ARISTOTLE Trial. CIRCULATION. 2018.
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
2018
Volume
138
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology